U.S. Digital Ovulation Test Kits Market: Institutional sales are expected to lead the market over the forecast period, generating a revenue of US$ 95.1 Mn by 2031

Digital ovulation tests help women to maximize the chances of conceiving naturally by identifying the two most fertile days of their menstrual cycle by measuring the changes in the level of luteinizing hormone (LH), which is important to fertility parameters. According to Future Market Insights (FMI) the U.S. Digital Ovulation Test Kits market is estimated to be US$ 80 Mn in 2021, and is expected to grow at a market CAGR of 9.6% during the forecast period (2021-2031)

Some of the digital devices available in the market have advanced features such as connectivity to Bluetooth or smart countdown. Clearblue, First Response and E.P.T. are some of the most popular digital ovulation test kits brands available in the U.S. market.

Increasing purchasing power and growing consumer awareness about women’s health are the two factors expected to drive the growth of the digital ovulation test kits market in the U.S. Various states in the country are focusing on improving women health through various awareness and healthcare programs.

For instance, the American pregnancy association along with its education partner Fairhaven Health LLC guides ovulation testing to couples trying to get pregnant. This is anticipated to boost the growth of the digital ovulation test kit market.

Rising first-time pregnancy demographics and decreasing fertility rates, along with rising levels of disposable income and growing advancements in ovulation testing are some of the major factors driving the growth of the digital ovulation test kit market in the U.S.

The COVID-19 pandemic has significantly affected the sale of digital ovulation test kits. The nationwide lockdown and disrupted supply chains have limited the availability of these products. The pandemic in the first few months of 2020 has negatively impacted the digital ovulation test kits market.

Get Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13241

Key Takeaways from the U.S. Digital Ovulation Test Kits Market Study

• Branded test kits are expected to dominate the U.S. digital ovulation test kits market, rising at a CAGR of around 3%.
• Institutional sales are expected to witness significant growth with easier access to patients driving a CAGR of around 8.8%.
• Home based use of digital ovulation test kits to gain traction owing to lower stress for use through menstrual cycles.
• Relatively higher costs to potentially limit sales of digital variants of ovulation test kits in the country.

“Increasing consumer awareness about fertility monitoring parameters, along with high cost and low accuracy associated with fertility treatments are expected to aid the demand for digital ovulation test kits in the U.S. through the end of the forecast period in 2031,” says the FMI Analyst

Request For Report TOC: https://www.futuremarketinsights.com/reports/digital-ovulation-test-kits-market/table-of-content

Who is Winning?

The U.S. market is set to expand strongly owing to the rising prevalence of fertility disorders and the adoption of digital ovulation test kits. Furthermore, the advancements in digital ovulation test kits are expected to boost market demand.

Manufacturers are currently focusing on designing novel offerings that can provide better results at a lower cost, while also providing simple and reliable outputs. Key manufacturers are signing strategic partnership agreement within the industry to expand their product portfolios across the U.S.

• In 2017, Sugentech, a major digital ovulation test kits manufacturer entered into a strategic partnership with CGETC, Inc., a consumer fulfilment and marketing company located in the U.S.

The business alliance aims to support the distribution of product portfolios across the country and emerging players are extending their partnership to strengthen their market presence.

• For instance, In February 2019 NFI Consumer Healthcare expanded the agreement with Callitas Health to distribute co-branded products such as NFI’s e.p.t, the leading Over-the-Counter (OTC) ovulation test kit in the U.S.

Key market players covered by FMI include Church & Dwight Co. Inc., Swiss Precision Diagnostics GmbH, Sugentech Inc., Gregory Pharmaceutical Holdings, Inc., iXensor Co. Ltd, Samplytics Technologies Private Limited, Bio-AMD, and others consolidating their positions through mergers, acquisitions and new product launches.

Any Queries, Contact us @ https://www.futuremarketinsights.com/ask-question/rep-gb-13241

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com